ORCHID PHARMA
Back to Income Statement
|
ORCHID PHARMA Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹1,398 Cr | ₹819 Cr | ₹666 Cr | ₹560 Cr | ₹450 Cr |
What is the latest Revenue of ORCHID PHARMA ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹1,398 Cr |
| Mar2025 | ₹819 Cr |
| Mar2024 | ₹666 Cr |
| Mar2023 | ₹560 Cr |
| Mar2022 | ₹450 Cr |
How is Revenue of ORCHID PHARMA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,398 Cr | 70.57 | |
| Mar2025 | ₹819 Cr | 23.05 | |
| Mar2024 | ₹666 Cr | 19.00 | |
| Mar2023 | ₹560 Cr | 24.33 | |
| Mar2022 | ₹450 Cr | - | |
Compare Revenue of peers of ORCHID PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ORCHID PHARMA | ₹6,632.1 Cr | 15.6% | 11% | 52.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,437.0 Cr | -0.5% | -3% | 16% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,054.0 Cr | 1.6% | 9.3% | 54.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,842.0 Cr | 3.5% | 2.3% | 40.6% | Stock Analytics | |
| CIPLA | ₹111,565.0 Cr | 1.6% | -3.2% | -11.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,163.0 Cr | 5.8% | 3.2% | -8.3% | Stock Analytics | |
ORCHID PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ORCHID PHARMA | 15.6% |
11% |
52.6% |
| SENSEX | 0.7% |
-3.9% |
-8.9% |
You may also like the below Video Courses